Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer
| Autor: | Moinpour, Carol1 cmoinpou@fhcrc.org, Donaldson, Gary, Liepa, Astra2, Melemed, Allen2, O'Shaughnessy, Joyce3, Albain, Kathy4 |
|---|---|
| Zdroj: | Quality of Life Research. Jun2012, Vol. 21 Issue 5, p765-775. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|